Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transverse Sinuses | 1 | 2022 | 29 | 0.900 |
Why?
|
| Craniotomy | 1 | 2022 | 731 | 0.650 |
Why?
|
| Waxes | 1 | 2016 | 20 | 0.590 |
Why?
|
| Palmitates | 1 | 2016 | 77 | 0.560 |
Why?
|
| Otologic Surgical Procedures | 1 | 2016 | 148 | 0.510 |
Why?
|
| Semicircular Canals | 1 | 2016 | 195 | 0.510 |
Why?
|
| Ear Diseases | 1 | 2016 | 178 | 0.500 |
Why?
|
| Temporal Bone | 1 | 2016 | 671 | 0.410 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2014 | 199 | 0.400 |
Why?
|
| Cerebral Palsy | 1 | 2014 | 433 | 0.360 |
Why?
|
| Cranial Sinuses | 1 | 2022 | 65 | 0.220 |
Why?
|
| Serine Proteases | 1 | 2021 | 47 | 0.210 |
Why?
|
| Facial Nerve | 1 | 2021 | 273 | 0.170 |
Why?
|
| Drug Therapy | 1 | 2021 | 517 | 0.170 |
Why?
|
| Skull | 1 | 2022 | 814 | 0.160 |
Why?
|
| Neuroma, Acoustic | 1 | 2021 | 439 | 0.160 |
Why?
|
| Acridines | 1 | 2016 | 21 | 0.150 |
Why?
|
| Cytostatic Agents | 1 | 2016 | 10 | 0.150 |
Why?
|
| G-Quadruplexes | 1 | 2016 | 77 | 0.140 |
Why?
|
| Injections, Intralesional | 1 | 2014 | 281 | 0.120 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 12530 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2021 | 2556 | 0.110 |
Why?
|
| Stomach Neoplasms | 1 | 2021 | 1243 | 0.110 |
Why?
|
| Models, Anatomic | 1 | 2016 | 687 | 0.110 |
Why?
|
| Cadaver | 1 | 2016 | 1362 | 0.110 |
Why?
|
| Telomerase | 1 | 2016 | 734 | 0.100 |
Why?
|
| Radiography | 1 | 2022 | 6976 | 0.100 |
Why?
|
| Telomere | 1 | 2016 | 844 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 2094 | 0.090 |
Why?
|
| Respiratory Sounds | 1 | 2014 | 694 | 0.090 |
Why?
|
| Airway Obstruction | 1 | 2014 | 649 | 0.090 |
Why?
|
| Laryngoscopy | 1 | 2014 | 719 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 4104 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 5034 | 0.070 |
Why?
|
| Oligopeptides | 1 | 2009 | 1230 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2009 | 2839 | 0.060 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2009 | 1191 | 0.060 |
Why?
|
| Hypothalamus | 1 | 2009 | 1062 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 4907 | 0.060 |
Why?
|
| Recovery of Function | 1 | 2014 | 2920 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2009 | 1205 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2009 | 2246 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2016 | 3345 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11238 | 0.050 |
Why?
|
| Platinum | 1 | 2021 | 218 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2021 | 3670 | 0.040 |
Why?
|
| Metagenomics | 1 | 2021 | 414 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2016 | 62039 | 0.040 |
Why?
|
| Humans | 11 | 2022 | 715594 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2021 | 23705 | 0.040 |
Why?
|
| Male | 7 | 2021 | 350143 | 0.040 |
Why?
|
| China | 1 | 2021 | 2234 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15900 | 0.030 |
Why?
|
| Microsurgery | 1 | 2021 | 811 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 8560 | 0.030 |
Why?
|
| Feces | 1 | 2020 | 1373 | 0.030 |
Why?
|
| Proteins | 1 | 2009 | 6071 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3631 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 2015 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2021 | 10600 | 0.030 |
Why?
|
| Neoplasms | 1 | 2021 | 20515 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2021 | 4035 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 20337 | 0.030 |
Why?
|
| Middle Aged | 4 | 2021 | 214639 | 0.030 |
Why?
|
| Apoptosis | 2 | 2021 | 9960 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 6631 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39334 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 34429 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2021 | 13203 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2014 | 41184 | 0.030 |
Why?
|
| Homeostasis | 1 | 2021 | 3328 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2009 | 231 | 0.020 |
Why?
|
| Female | 6 | 2021 | 377052 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2021 | 2033 | 0.020 |
Why?
|
| Preoptic Area | 1 | 2009 | 152 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2009 | 8525 | 0.020 |
Why?
|
| Mitochondria | 1 | 2021 | 3613 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 6476 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 4026 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 2009 | 871 | 0.020 |
Why?
|
| Pituitary-Adrenal System | 1 | 2009 | 510 | 0.020 |
Why?
|
| DNA Damage | 1 | 2016 | 2429 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2009 | 661 | 0.020 |
Why?
|
| Disease Progression | 1 | 2021 | 13219 | 0.020 |
Why?
|
| Aged | 3 | 2021 | 162392 | 0.020 |
Why?
|
| Random Allocation | 1 | 2009 | 2442 | 0.020 |
Why?
|
| Animals | 4 | 2021 | 169173 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 8996 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2021 | 21804 | 0.020 |
Why?
|
| Rats | 2 | 2009 | 24794 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 11956 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 40040 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 51354 | 0.010 |
Why?
|
| Mutation | 1 | 2021 | 29253 | 0.010 |
Why?
|
| Pregnancy | 1 | 2009 | 27362 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 212237 | 0.000 |
Why?
|
Concepts
(96)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(3)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_